sEH inhibitor-20 is a metabolically stable, orally active sEH inhibitor with an IC50 of 0.2 nM. It exhibits significant analgesic and anti-inflammatory properties, making it a promising candidate for researching neuropathic pain.
Target:
Epoxide Hydrolase
* VAT and and shipping costs not included. Errors and price changes excepted
